<DOC>
	<DOCNO>NCT02324400</DOCNO>
	<brief_summary>The study intend verify safety assess performance 3-days treatment protocol RenaSense System ADHF patient .</brief_summary>
	<brief_title>Pilot Study Evaluation Safety Performance RenaSense System Hospitalized Acute Decompensated Heart Failure Patients</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>1 . Females 2 . Age 1885 year 3 . Admitted hospital primary diagnosis decompensated heart failure 4 . Estimated glomerular filtration rate ( GFR ) * ≤60 ml/min ≥20 ml/min , base serum creatinine initial evaluation 5 . History chronic use oral loop diuretic ( ≥ 80 mg/day Furosemide equivalent ) past 3 month 6 . Indication treatment intravenous diuretic 7 . Volume overload For patient pulmonary artery catheter , persistent volume overload include : Pulmonary capillary wedge pressure great 22mmHg one follow clinical sign : least 2+ peripheral edema and/or Pulmonary edema pleural effusion chest xray For patient without pulmonary artery catheter , persistent volume overload include least two follow : At least 2+ peripheral edema Jugular venous pressure great 10 cm physical examination ( central venous pressure great 10 mmHg measure ) pulmonary edema pleural effusion chest xray 8 . Indication urinary catheterization 9 . BNP &gt; 400 pg/mL initial evaluation 10 . Able willing sign inform consent 1 . History urinary tract infection within last 1 month base medical history and/or urinalysis day admission 2 . Gross hematuria , perineal hematoma symptomatic microscopic hematuria 3 . Hypertension , systolic &gt; 180 mmHg diastolic &gt; 110 mmHg 4 . Hypotension , systolic pressure &lt; 100 mmHg 5 . Status post renal denervation 6 . Implanted cardiac rhythm management device pacemaker , cardiac resynchronization therapy ( CRT ) , Implantable cardioverterdefibrillator ( ICD ) 7 . Suspected known pregnancy 8 . Previous organ transplantation 9 . Life threaten condition severe infection , malignancy infarction 10 . Subject participate concurrent clinical investigation 11 . Diseases condition , judgment investigator , preclude participation clinical trial</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>